As the pressure on the labor market becomes greater, businesses are seeking talent from untapped pipelines to meet their hiring needs. More focus is on hiring workers under the age of 18 and still in high school. Join us for a conversation highlighting the opportunities and best practices for connecting to this emerging workforce!
Join us in-person or via livestream for a conversation about the tremendous growth in the Cell and Gene Therapy field. Please make reservations by Tuesday, March 15th. We cannot accommodate walk-ins. The event is presented by Columbus Metropolitan Club, hosted by Eddie Pauline, BioOhio President & CEO, and features • Timothy J. Miller, Ph.D.,CEO, President and Co-Founder, Forge Biologics • BioOhio Board Member Eli Phillips Jr., PharmD, Vice President for Specialty Solutions, Cardinal Health • Samantha M. Jaglowski, M.D., Associate Professor of Hematology, Medical Director of the Blood and Marrow Transplant Program, and member of the Leukemia Research Program, The James Comprehensive Cancer Center at The Ohio State University.
Every third Friday of the month, G2G hosts this online event to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities, such as grants and BAAs that could accelerate company growth. We will share insights from our research and provide some Q&A during the first half hour. We then take a deeper dive on non-dilutive federal government funding sources and related priorities with consultation during the second half hour for our customers.
In the United States, the CDC estimates that 100,000 Americans have sickle cell disease (SCD). About 90% of people with SCD are of African descent. SCD also occurs in Hispanic, South Asian, Middle Eastern, and Southern European ancestry. A panel of experts, moderated by BioOhio's Eddie Pauline, will discuss current programs that assist patients and families, as well as how Ohio’s hospital and health systems are contributing to SCD research and advancements in treatment.
Join JumpStart on Wednesday, March 23, for the next Founders Unfiltered featuring Dr. Dan German, founder of orthobrain. An award-winning orthodontist, Dr. German is well known throughout the dental world. Now he’s helping dentists seamlessly integrate orthodontics into their practice by providing education and real-time support through orthobrain’s innovative platform. Tune in to find out how Dr. German set out to resolve the unmet demand for orthodontics and hear more about how he went from dental practitioner to tech founder.
This event is presented by Project Medtech. Grab your favorite drink (or just a drink), come learn and interact with industry experts while they discuss hot topics in Medtech. Dr. Ashley Mooneyham is President and Director of Grants at Superior Medical Experts, a medical writing and research support company. As Director of Grants, she has helped small businesses in the healthcare innovation space secure over $14 million in non-dilutive seed funding through the SBIR/STTR grant program. Superior Medical Experts provides comprehensive grant assistance that spans company registrations, grant strategy consulting, full research and compliance drafting, and submission in as little as 12 weeks.
With the EU Medical Device Regulation (MDR) now fully applicable, manufacturers are facing the challenges of both transitioning legacy devices to the MDR, and introducing new products. Although the Medical Device Coordination Group (MDCG) guidance has been forthcoming, there remain significant gaps in guidance and interpretation of requirements, and varying interpretations of expectations. In addition with the limited number of Notified Bodies designated under the MDR, there is substantial pressure to make MDR submissions as soon as possible to avoid the “cliff edge” of May 2024. NAMSA invites you to join this upcoming webinar as our team of regulatory experts discuss practical insights to address these challenges.
The surge in digital healthcare technologies has reshaped the healthcare experience for consumers. Consumers are looking for more personalized health experiences where they are in control of their health but they are also more aware of the risks and benefits of sharing their data. Now more than ever, it’s important organizations understand how to use technology to deliver value while addressing consumer concerns around data, consent and security.
For patients on Medicare, the majority of whom are over age 65, time matters. However, newly published research from the Stanford Byers Center for Biodesign shows that patients can wait up to 5 years after FDA authorization to access new medical technologies. Instead, a well-designed transitional coverage program could greatly accelerate patients’ access to care, while reducing the overall cost burden on our healthcare system. This program would also encourage innovation in areas of critically important unmet clinical needs. The Duke-Margolis Center for Health Policy has recommended the addition of several key elements to a transitional coverage pathway, highlighting the need for early engagement between stakeholders to inform and guide evidence development and appropriate use of novel technologies. Please join us to explore these findings and hear the perspectives of physicians, innovators and CMS stakeholders on this important initiative to advance patient care.
The Conference on Innovations in Climate Resilience, presented by Battelle in collaboration with DOE National Laboratories, offers a curated technical program with invited keynote presentations, platform and lightning talks and a poster reception. We’re expecting an audience of government leaders, entrepreneurs and innovators to explore breakthroughs in technology, science, policy and infrastructure that will help mitigate the threats to our environment, health, communities, national security and economic well-being from a changing climate.